Jacobson Pharma Corporation Limited ( (HK:2633) ) has issued an update.
Jacobson Pharma Corporation Limited has entered into a Subscription Agreement with Tycoon Group Holdings Limited to subscribe for 94,000,000 shares at HK$0.500 each, representing a premium over recent market prices. This transaction is classified as a discloseable transaction under the Listing Rules, requiring reporting and announcement but not shareholder approval, potentially enhancing Jacobson Pharma’s market presence and investment portfolio.
More about Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited is a company incorporated in the Cayman Islands, primarily engaged in the pharmaceutical industry. It focuses on the development, production, and distribution of pharmaceutical products.
YTD Price Performance: 24.00%
Average Trading Volume: 1,297,234
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.36B
For a thorough assessment of 2633 stock, go to TipRanks’ Stock Analysis page.